(redirected from Therapeutic drug monitoring)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.


1. The total demand for all goods and services in an economy. One calculates the absorption by adding the value of all goods and services produced and consumed locally to that of all imports.

2. A French term for acquisition.


the sharing of indirect costs or OVERHEADS to units of product by means of COST RATES. Provided that actual overheads do not exceed BUDGET and that actual output is the same as budgeted output, then the overhead cost rate should allow total product cost to be determined, and a selling price set which will recover the overhead costs involved in producing and selling the product. See STANDARD COST, OVERHEAD COST VARIANCE.
References in periodicals archive ?
Which methodology has been used in the past for drugs-of-abuse screening and therapeutic drug monitoring, and what main limitation has been observed?
The competitive landscape covers the various strategies adopted by industry players to maintain their position in the therapeutic drug monitoring market.
Resolution of disparities in the foreign-born TB population, confrontation of treatment complexities in MDR TB cases, and determination of the most appropriate application and interpretation of therapeutic drug monitoring are required.
In a study of patients in 10 different clinics in which therapeutic drug monitoring is recommended for all patients with multidrug-resistant TB, only 45% of 109 eligible patients received such monitoring, the investigators found (Chest 2004;126:1770-6).
com) added a page of links to recent articles, conference summaries, news reports, and other information about therapeutic drug monitoring in HIV treatment.
One trend in the global therapeutic drug monitoring market is advent of POC tests.
Certainly, the amikacin pharmacokinetics support this finding, but the suggestion of routine use of CysC for therapeutic drug monitoring on the basis of these results is premature.
Among the topics are infections agents and drugs of choice, mechanisms of action and routes of administration of antimicrobial agents, therapeutic drug monitoring, recommended antimicrobial prophylaxis for selected infectious agents and conditions, and formulary.
CEDIA is known worldwide for immunoassays in drugs-of-abuse screening, therapeutic drug monitoring (TDM), and specifically immunosuppressant drug (ISD) monitoring.
They provide step-by-step procedures for the analysis of analytes of clinical importance in a variety of applications, and cover mass spectrometry methods for analytes including drugs, hormones, and metabolic compounds in toxicology, therapeutic drug monitoring, endocrinology, and pediatric metabolism.
Another area that is being actively being researched is therapeutic drug monitoring.
These applications are particularly suited for laboratories conducting analyses involving drug testing, therapeutic drug monitoring, environmental toxicology, and forensic applications.

Full browser ?